Cellebrite DI (CLBT) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cellebrite DI Ltd. has released its interim consolidated financial statement for June 30, 2024, showing total assets of $556,583 thousand, an increase from $532,885 thousand at the end of 2023. However, the shareholders’ deficiency equity stands at ($40,159) thousand, a decrease from a positive equity of $34,212 thousand previously. The company’s long-term liabilities have also seen a significant rise, indicating a notable shift in the company’s financial health.
For further insights into CLBT stock, check out TipRanks’ Stock Analysis page.